October 11, 2012 -- “The Team of TheBioTechPanel Inc. is proud to announce the addition of ReNeuron Group’s interview to its´ Internet-TV site, TheBioTechPanel-TV.com.
About ReNeuron Group:
ReNeuron Group is a leading, clinical-stage stem cell business. The primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need. We have used our unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional drug treatments. Our lead therapeutic candidate is our ReN001 stem cell therapy for the treatment of patients left disabled by the effects of a stroke. This treatment is currently in clinical development. We are also developing stem cell therapies for other conditions such as peripheral arterial disease, a serious and common side effect of diabetes, and blindness-causing diseases of the retina. We have also developed a range of stem cell lines for non-therapeutic applications – our ReNcell® products for use in academic and commercial research. Our ReNcell®CX andReNcell®VM neural cell lines are marketed worldwide under license by USA-based Merck Millipore.
Our shares are traded on the London AIM market under the symbol RENE.L. For more information please visit our webpage www.reneuron.com.
About TheBioTechPanel-TV.com:
The site’s goal is to boost awareness for Life Science Companies and their products, services, licensing deals, funding plans, trials, news, stock quotations etc., by approaching a broad target group of retail and institutional investors in Europe and globally.
How does it work? Very simple: You just send us a video presentation of your choice, and we will be pleased to load it onto our Internet-TV site. Then, we market the new video via different news channels, thereby raising attention for your Company. Also, with every new announcement for someone else’s video, your Company will additionally be in the focus of investors.
For whom is this offer interesting? For every Life Science Company which is interested in boosting awareness. The monthly costs are affordable (especially when compared to expensive and not as effective roadshows); moreover, it is permanent and can be updated with new video presentations on a monthly basis.
Any questions? Please contact us at tv@thebiotechpanel.com
Frank Rothmaier
TheBioTechPanel Inc.
Tel.: +1 561 213 4486 (USA)
+49 172 952 9418 (GER)
f.rothmaier@thebiotechpanel.com
